BioConsortia, Inc.

BioConsortia is pleased to announce a commercial launch with Hodder and Taylors Ltd (H&T) to introduce FixiN 33, a nitrogen-fixing microbial seed treatment, to New Zealand farmers for the 2025 season.   This collaboration follows multiple years of successful field trials in New Zealand and internationally, demonstrating FixiN 33’s efficacy in reducing nitrogen fertilizer requirements while maintaining crop yields. With a shelf life of over two years and extended on-seed stability, this product delivers robust performance aligned with the needs of modern agriculture.   Learn more about this partnership and its potential to enhance productivity and sustainability in agriculture: https://lnkd.in/g-b4eUWY

We are pleased to share that BioConsortia’s AMARA™ biofungicide has been granted US EPA registration. AMARA is designed to protect high-value fruit and vegetable crops from foliar diseases with a consistent, biological mode of action, providing growers with an effective alternative to chemical fungicides. AMARA features a high concentration of an environmentally stable active ingredient, enabling greater efficacy and reliability compared to existing biological products. This milestone is part of BioConsortia’s ongoing effort to develop natural solutions for sustainable agriculture. AMARA will be marketed by Nichino America, Inc., with product availability expected for the 2025 use season. Read: (https://lnkd.in/gFint2C8) For more information, please contact [email protected]

BioConsortia is seeking a Formulation Scientist to join its R&D team in Davis, California.  This will be a senior level position responsible for formulation development of microbial biopesticides and biostimulants and managing formulation lab operations.  The successful candidate will work closely with all levels of the Company’s R&D team. For more information: https://lnkd.in/gS2CW6Nv

BioConsortia is seeking a research associate to join its process development team in Davis, California. This position will be responsible for fermentation and downstream process optimization of microbial products for agricultural application. The successful candidate will work closely with all members of the company’s fermentation and formulation teams. For more information: https://lnkd.in/gYxCzhGf

BioConsortia is seeking a fermentation scientist/process engineer to join its process development team in Davis, California. This position will be responsible for fermentation optimization, scale up and manufacturing tech transfer of microbial products for agricultural application. The successful candidate will work closely with fermentation and formulation scientists as well as external scale up and manufacturing collaborators.  For more information: https://lnkd.in/giwYqFMD

BioConsortia’s VP of Business Development, Sarah Reiter, will be attending the World Agri-Tech Innovation Summit in London at the end of the month.   Sarah is available to discuss BioConsortia’s groundbreaking work in microbial solutions for improved crop performance. If you are interested in scheduling a meeting to explore potential collaborations, please reach out directly to Sarah or [email protected].   #WorldAgriTech #AgTech #MicrobialSolutions #BioConsortia #CropInnovation #UnleashThePowerOfMicrobes

BioConsortia CEO Marcus Meadows-Smith shares insights in S&P Global's 2024 Biologicals Review. He discusses our upcoming launches, including Amara (foliar fungicide) and Always N (nitrogen-fixing seed treatment), and highlights the performance of Solvarix (bionematicide). Learn more about how BioConsortia’s microbial innovations are shaping the future of agricultural biologicals. Read the full interview here: https://lnkd.in/gu4KWtes #Biologicals #CropProtection #NitrogenFixation #BioConsortia #UnleashThePowerOfMicrobes

BioConsortia has released the latest findings from our bionematicide trials conducted in Brazil. Our advanced bionematicide, SOLVARIX, has exhibited strong performance in managing plant parasitic nematodes in corn and soy crops. The trials have confirmed SOLVARIX's efficacy, enhancing yield, promoting robust root development, and offering prolonged stability on the seed, ensuring long-term effectiveness. This product is positioned as an effective seed treatment option for nematode control. For more details on the trial results and insights into SOLVARIX's impact on sustainable agriculture, please read the full article here: https://lnkd.in/gc7pkX6G

We are pleased to share that BioConsortia's Director of Plant Pathology, Debora Wilk, will be speaking at the Biocontrol & Biostimulants LATAM conference next week.   Dr. Wilk will present on the "Compelling effects of SOLVARIX on the control of Plant Parasitic Nematodes and Soil Insects, in Corn and Soy.   SOLVARIX is a bionematicide offering: • Unique mode of action • Superior efficacy • Higher yield • Robust root colonization with extended stability, ideal for seed treatment • Broad spectrum control on nematodes and soil insects in corn and soy   We invite you to join us at the conference to learn more about how SOLVARIX is contributing to advancements in crop protection and agricultural productivity in corn and soy. https://lnkd.in/g_BaHbnp

We are seeking a Director of Regulatory Affairs at BioConsortia. Check out the job description at https://lnkd.in/dH6M4czc and consider joining our vibrant and innovative team.